UPDATE | August 3, 2026

How are geopolitical factors influencing sourcing and manufacturing decisions for 2026 and beyond?

  • MAIL

Geopolitical developments are influencing how biopharmaceutical companies approach sourcing and manufacturing for 2026 and beyond. Trade policy shifts, supply chain vulnerabilities, and regional conflicts are prompting organizations to reassess production locations and supplier relationships. In a Pharma's Almanac roundtable, James Choi, EVP and Head of Global Public Affairs, discusses these dynamics and their implications for the industry, including approaches to building resilience and managing operational risk.


Read the full article here for the complete discussion.

Geopolitical developments are influencing how biopharmaceutical companies approach sourcing and manufacturing for 2026 and beyond. Trade policy shifts, supply chain vulnerabilities, and regional conflicts are prompting organizations to reassess production locations and supplier relationships. In a Pharma's Almanac roundtable, James Choi, EVP and Head of Global Public Affairs, discusses these dynamics and their implications for the industry, including approaches to building resilience and managing operational risk.


Read the full article here for the complete discussion.

Share article

  • MAIL

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required